Free Trial

CVC Income & Growth (CVCE) Competitors

GBX 1.05 -0.01 (-0.85%)
As of 06:14 AM Eastern

CVCE vs. HOYE, BPCR, TERN, TFG, and USG

Should you buy CVC Income & Growth stock or one of its competitors? MarketBeat compares CVC Income & Growth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CVC Income & Growth include Honye Financial Services (HOYE), BioPharma Credit (BPCR), Tern (TERN), Tetragon Financial (TFG), and Ultimate Sports Group (USG). These companies are all part of the "asset management" industry.

How does CVC Income & Growth compare to Honye Financial Services?

Honye Financial Services (LON:HOYE) and CVC Income & Growth (LON:CVCE) are both small-cap financial services companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

In the previous week, Honye Financial Services' average media sentiment score of 0.00 equaled CVC Income & Growth'saverage media sentiment score.

Company Overall Sentiment
Honye Financial Services Neutral
CVC Income & Growth Neutral

Honye Financial Services has a net margin of 0.00% compared to CVC Income & Growth's net margin of -20.03%. CVC Income & Growth's return on equity of -2.11% beat Honye Financial Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Honye Financial ServicesN/A -104.63% -34.81%
CVC Income & Growth -20.03%-2.11%N/A

2.9% of CVC Income & Growth shares are owned by institutional investors. 9.5% of Honye Financial Services shares are owned by company insiders. Comparatively, 0.1% of CVC Income & Growth shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

CVC Income & Growth is trading at a lower price-to-earnings ratio than Honye Financial Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Honye Financial ServicesN/AN/AN/A-£0.01N/A
CVC Income & Growth£18.73M0.16N/A-£4.94N/A

Summary

CVC Income & Growth beats Honye Financial Services on 5 of the 8 factors compared between the two stocks.

How does CVC Income & Growth compare to BioPharma Credit?

BioPharma Credit (LON:BPCR) and CVC Income & Growth (LON:CVCE) are both small-cap financial services companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and dividends.

BioPharma Credit has a beta of 0.22126153, meaning that its share price is 78% less volatile than the broader market. Comparatively, CVC Income & Growth has a beta of 0.18503673, meaning that its share price is 81% less volatile than the broader market.

31.7% of BioPharma Credit shares are owned by institutional investors. Comparatively, 2.9% of CVC Income & Growth shares are owned by institutional investors. 0.1% of BioPharma Credit shares are owned by company insiders. Comparatively, 0.1% of CVC Income & Growth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

BioPharma Credit pays an annual dividend of GBX 7 per share and has a dividend yield of 738.4%. CVC Income & Growth pays an annual dividend of GBX 7.49 per share and has a dividend yield of 712.3%. BioPharma Credit pays out 61.4% of its earnings in the form of a dividend. CVC Income & Growth pays out -151.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

BioPharma Credit has higher revenue and earnings than CVC Income & Growth. CVC Income & Growth is trading at a lower price-to-earnings ratio than BioPharma Credit, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioPharma Credit£132.06M0.08£10.42B£11.400.08
CVC Income & Growth£18.73M0.16N/A-£4.94N/A

In the previous week, BioPharma Credit's average media sentiment score of 2.00 beat CVC Income & Growth's score of 0.00 indicating that BioPharma Credit is being referred to more favorably in the media.

Company Overall Sentiment
BioPharma Credit Very Positive
CVC Income & Growth Neutral

BioPharma Credit has a net margin of 92.62% compared to CVC Income & Growth's net margin of -20.03%. BioPharma Credit's return on equity of 11.29% beat CVC Income & Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
BioPharma Credit92.62% 11.29% 4.98%
CVC Income & Growth -20.03%-2.11%N/A

Summary

BioPharma Credit beats CVC Income & Growth on 10 of the 13 factors compared between the two stocks.

How does CVC Income & Growth compare to Tern?

CVC Income & Growth (LON:CVCE) and Tern (LON:TERN) are both small-cap financial services companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, media sentiment, earnings and profitability.

2.9% of CVC Income & Growth shares are owned by institutional investors. Comparatively, 1.1% of Tern shares are owned by institutional investors. 0.1% of CVC Income & Growth shares are owned by company insiders. Comparatively, 6.6% of Tern shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, CVC Income & Growth's average media sentiment score of 0.00 equaled Tern'saverage media sentiment score.

Company Overall Sentiment
CVC Income & Growth Neutral
Tern Neutral

CVC Income & Growth has a beta of 0.18503673, meaning that its stock price is 81% less volatile than the broader market. Comparatively, Tern has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market.

CVC Income & Growth has a net margin of -20.03% compared to Tern's net margin of -7,033.60%. CVC Income & Growth's return on equity of -2.11% beat Tern's return on equity.

Company Net Margins Return on Equity Return on Assets
CVC Income & Growth-20.03% -2.11% N/A
Tern -7,033.60%-19.70%-5.04%

CVC Income & Growth has higher revenue and earnings than Tern. Tern is trading at a lower price-to-earnings ratio than CVC Income & Growth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVC Income & Growth£18.73M0.16N/A-£4.94N/A
Tern£29.40K327.35-£16.02M-£0.37N/A

Summary

CVC Income & Growth beats Tern on 6 of the 10 factors compared between the two stocks.

How does CVC Income & Growth compare to Tetragon Financial?

Tetragon Financial (LON:TFG) and CVC Income & Growth (LON:CVCE) are both small-cap financial services companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, risk, analyst recommendations and media sentiment.

Tetragon Financial has a net margin of 70.54% compared to CVC Income & Growth's net margin of -20.03%. Tetragon Financial's return on equity of 19.70% beat CVC Income & Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
Tetragon Financial70.54% 19.70% 3.14%
CVC Income & Growth -20.03%-2.11%N/A

Tetragon Financial pays an annual dividend of GBX 44 per share and has a dividend yield of 369.7%. CVC Income & Growth pays an annual dividend of GBX 7.49 per share and has a dividend yield of 712.3%. Tetragon Financial pays out 5.8% of its earnings in the form of a dividend. CVC Income & Growth pays out -151.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. CVC Income & Growth is clearly the better dividend stock, given its higher yield and lower payout ratio.

Tetragon Financial has a beta of 0.46, suggesting that its share price is 54% less volatile than the broader market. Comparatively, CVC Income & Growth has a beta of 0.18503673, suggesting that its share price is 81% less volatile than the broader market.

In the previous week, Tetragon Financial's average media sentiment score of 0.00 equaled CVC Income & Growth'saverage media sentiment score.

Company Overall Sentiment
Tetragon Financial Neutral
CVC Income & Growth Neutral

Tetragon Financial has higher revenue and earnings than CVC Income & Growth. CVC Income & Growth is trading at a lower price-to-earnings ratio than Tetragon Financial, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tetragon Financial£751.20M0.01£12.66B£759.000.02
CVC Income & Growth£18.73M0.16N/A-£4.94N/A

0.9% of Tetragon Financial shares are held by institutional investors. Comparatively, 2.9% of CVC Income & Growth shares are held by institutional investors. 31.2% of Tetragon Financial shares are held by company insiders. Comparatively, 0.1% of CVC Income & Growth shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Tetragon Financial beats CVC Income & Growth on 8 of the 12 factors compared between the two stocks.

How does CVC Income & Growth compare to Ultimate Sports Group?

CVC Income & Growth (LON:CVCE) and Ultimate Sports Group (LON:USG) are both small-cap asset management industry companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, risk, valuation, analyst recommendations, dividends, earnings and profitability.

In the previous week, CVC Income & Growth's average media sentiment score of 0.00 equaled Ultimate Sports Group'saverage media sentiment score.

Company Overall Sentiment
CVC Income & Growth Neutral
Ultimate Sports Group Neutral

Ultimate Sports Group has a net margin of 0.00% compared to CVC Income & Growth's net margin of -20.03%. Ultimate Sports Group's return on equity of 0.00% beat CVC Income & Growth's return on equity.

Company Net Margins Return on Equity Return on Assets
CVC Income & Growth-20.03% -2.11% N/A
Ultimate Sports Group N/A N/A N/A

CVC Income & Growth is trading at a lower price-to-earnings ratio than Ultimate Sports Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVC Income & Growth£18.73M0.16N/A-£4.94N/A
Ultimate Sports Group£1.69M0.00N/A-£0.40N/A

2.9% of CVC Income & Growth shares are held by institutional investors. 0.1% of CVC Income & Growth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

CVC Income & Growth beats Ultimate Sports Group on 4 of the 7 factors compared between the two stocks.

Get CVC Income & Growth News Delivered to You Automatically

Sign up to receive the latest news and ratings for CVCE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CVCE vs. The Competition

MetricCVC Income & GrowthAsset Management IndustryFinancial SectorLON Exchange
Market Cap£2.92M£2.37B£5.75B£2.73B
Dividend Yield6.84%6.03%5.29%6.13%
P/E Ratio-0.2125.7716.32366.58
Price / Sales0.162,070.881,486.9886,601.26
Price / CashN/A60.3390.2527.87
Price / BookN/A1.356.507.64
Net IncomeN/A£265.36M£1.13B£5.89B
7 Day PerformanceN/A-0.95%-0.20%-1.18%
1 Month Performance0.10%-0.84%0.47%0.65%
1 Year Performance-3.58%9.23%18.27%69.80%

CVC Income & Growth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CVCE
CVC Income & Growth
N/AGBX 1.05
-0.8%
N/A-2.7%£2.92M£18.73MN/AN/A
HOYE
Honye Financial Services
N/AN/AN/AN/A£11.10MN/AN/AN/A
BPCR
BioPharma Credit
N/AGBX 0.96
+0.4%
N/A+8.2%£10.80M£132.06M0.08N/A
TERN
Tern
N/AGBX 1.36
-4.4%
N/A-22.9%£10.50M£29.40KN/A8
TFG
Tetragon Financial
N/AGBX 12.25
-1.6%
N/A-12.2%£10.25M£751.20M0.02N/A

Related Companies and Tools


This page (LON:CVCE) was last updated on 6/11/2026 by MarketBeat.com Staff.
From Our Partners